Effects of paclitaxel liposome combined with epirubicin on the positive expression of DBC1 and SIRT1 in patients with advanced breast cancer

HUANG Jiayan; CHEN Xingrong; YANG Rui

doi:10.3969/j.issn.1002-7386.2019.05.016

Home>Articles>Effects of paclitaxel liposome combined with epirubicin on the positive expression of DBC1 and SIRT1 in patients with advanced breast cancer

DOI: 10.3969/j.issn.1002-7386.2019.05.016

Effects of paclitaxel liposome combined with epirubicin on the positive expression of DBC1 and SIRT1 in patients with advanced breast cancer

HUANG Jiayan

CHEN Xingrong

YANG Rui

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 707-709,713 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2019,41(5)